System Transmission

Top Signal

100#1 JOB

Activity

2176Ripe

+932 today

System

Livenow

Terminal Asset View

stockNASDAQ

TSHA

$4.49-2.60%

Taysha Gene Therapies Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

23Overripe

Live Analysis Active

Company Mission

Taysha Gene Therapies creates treatments for rare genetic brain diseases by fixing faulty genes. They work on therapies for conditions like Tay-Sachs disease and other neurological disorders. The company makes money through research funding and aims to eventually sell approved treatments to hospitals and patients who need them.

TSH

Industry Context

The biotech industry focuses on developing medical treatments using biological systems. Gene therapy companies like Taysha work on fixing genetic problems at their source, which is a cutting-edge but risky field. These companies often see big price swings around clinical trial results and regulatory decisions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

83Matrix

Market Momentum

43.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.9x— Normal Volume

Today's Change

-2.60%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing TSHA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:53 PM UTC

As-of 03-14-2026 18:38 UTC

Develops Gene Therapies for rare neurological diseases and makes money by selling treatments to hospitals and through insurance reimbursements.

Technical squeeze detected near recent lows, suggesting potential for a sharp breakout move in either direction as pressure builds.

Biotech sector showing volatility as FDA decisions approach, with Gene therapy companies facing binary outcomes that create high-risk, high-reward, suggesting high-risk, high-reward.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...